What Really Happens at a Clinical Trial: A Day-One Walkthrough

July 17, 2026 By admin Clinical Trials

Some links in this article are partner links. If you sign up through one, we may earn a commission at no cost to you. It never changes which panels we recommend or what we say about them.

Contents

If you have never been inside a research clinic, the unknown does most of the scaring. Is it safe? Will they spring something on you? Are you signing your rights away? Can you leave if it stops feeling right?

Fair questions. We connect people with paid studies every day, and the pattern is consistent: the volunteers who feel confident on day one are the ones who knew what was coming. So here is the full walkthrough — the screening visit, the consent process, the baseline tests, what a study day actually looks like, and when payment arrives.

One thing before we start: clinical trials are real medical research, and real research carries real medical risk. The compensation exists to reimburse your time and travel — it is not hazard pay, and it is never a reason to ignore risk. If a trial interests you, discuss it with your own doctor before committing. That is not boilerplate. It is how this is supposed to work.

See which trials you may qualify for →

Before day one: the pre-screen

You will not walk into a clinic cold. Nearly every study starts with a short questionnaire — online or by phone — covering the basics: age, general health, medications, smoking status, and whether you have the condition being studied (or, for healthy volunteer studies, whether you don't).

Be honest here, for the obvious reason and a practical one: eligibility criteria exist to keep you safe, and they get re-checked with lab work later anyway. Fudging an answer on the phone just wastes a trip.

Also know this going in: most applicants do not qualify for any given trial. Study protocols are narrow on purpose. Getting screened out is normal, usually says nothing about your health, and does not stop you from matching with a different study later.

The screening visit: your actual day one

If the pre-screen goes well, you will be invited to a screening visit at the research site. Expect it to take one to three hours. Bring a photo ID, your medication list, and your questions.

Informed consent comes first — before any needle

Before anyone examines you, you will sit down with a study coordinator and go through the informed consent document. This is the single most important part of the day.

The consent form must spell out, in plain language: what the study is testing, what procedures you will undergo, the known and potential risks, the possible benefits (including "none to you directly"), how your data will be protected, what compensation is offered, and whom to call with concerns. Drug trials in the US are overseen by an Institutional Review Board (IRB) — an independent committee whose job is to protect participants — and federal regulations require this consent process. Legitimate studies never skip it; a site that rushes you past consent is a site to walk away from.

Take your time. Ask anything. You can take the document home, show it to your doctor, and sleep on it. Signing is not a contract to finish the study — you keep the right to withdraw at any time, for any reason, without penalty. That right is printed in the document itself.

The baseline tests

Once you have signed consent — and only then — the medical part begins. A typical screening panel looks like this:

Vital signs: blood pressure, heart rate, temperature
Height and weight
A blood draw and a urine sample
An ECG (electrocardiogram) — sticker electrodes on your chest for a few minutes, painless

A medical history review with a nurse or physician
Depending on the study: a physical exam, drug and nicotine screening, or condition-specific tests

Some screening visits require fasting — the site will tell you beforehand. None of this is treatment. It is a snapshot of your health that determines whether you fit the protocol and gives researchers a baseline to compare against later.

Then you wait

Lab results take days, sometimes a week or two. The site will call either way. If you "screen-fail," that is protocol math, not a verdict on you — a single out-of-range lab value is enough. If you pass, you will be scheduled for your first study visit.

If you qualify: what a study day looks like

The details depend on the study design, but nearly everything falls into two shapes.

Outpatient visits. You come in, do the visit, go home. A visit might involve taking a study medication under observation, blood draws at timed intervals, symptom questionnaires, or device monitoring. Visits run from thirty minutes to most of a day. Many trials for ongoing conditions work this way — a series of outpatient visits over weeks or months.

Inpatient stays. Early-phase studies, especially with healthy volunteers, often require staying at the research unit — sometimes overnight, sometimes several days — so staff can monitor you continuously and draw blood on a fixed schedule. Think dorm-style rooms, meals provided, Wi-Fi, plenty of downtime between draws, and no leaving the unit mid-stay. Bring a book.

Either way, you are never on your own. Study staff monitor you throughout, and any side effect — even one that seems minor — should be reported immediately. That is not just for your safety; it is literally the data the study exists to collect.

Your rights do not end at the signature

Worth repeating, because these are the protections most first-timers do not know they have:

You can withdraw at any time. Mid-study, mid-visit, mid-sentence. No reason required, no penalty.
Compensation is typically prorated. Ethical studies pay for the visits you completed, not all-or-nothing — FDA guidance discourages payment designs that hold your entire payment hostage to finishing.
You can escalate concerns. The consent form lists a contact at the IRB, independent of the research site.

When — and how much — do you get paid?

Plainly: payouts vary enormously, and nothing is guaranteed until it is written in the consent document you signed.

As broad reference points, simple outpatient visits commonly compensate roughly $75–$300 per visit, while multi-day inpatient stays in early-phase studies commonly run into the low thousands for a full stay — with totals depending on length, phase, and location. Some studies compensate the screening visit; many do not. The exact schedule is in your consent form, in writing, before you commit.

Timing: many sites pay per completed visit — often by reloadable debit card or check within a few weeks — while others pay in installments or after the final visit. Ask at screening; sites answer this question all the time. And remember the framing ethical research uses: this is compensation for your time and travel, not a wage and not a windfall. Study compensation is also generally taxable income, so keep your own records.

For a fuller breakdown of what different study types tend to pay, see our guide to getting paid for clinical trials in 2026.

Questions worth asking at your screening visit

Bring these written down:

What is being tested, and what phase is this study?
What are the known side effects seen so far?
How many visits, and how long is each one?
What is the compensation schedule, and is screening compensated?
What happens if I withdraw partway through?
Who do I call — day or night — if I feel unwell?

A good site will answer all six without flinching. Hesitation on any of them is your cue to look elsewhere.

The bottom line

Day one of a clinical trial is mostly paperwork, conversation, and routine tests — with your consent gathered carefully before any of it happens. The fear of the unknown is usually worse than the day itself. The medical risk, though, is real, which is why the consent process exists and why your doctor should be in the loop before you sign anything.

When you are ready to see what is actually recruiting, you have two easy starting points: browse open studies in our paid studies directory, or answer a few questions and let a matching service do the narrowing for you.